(Q38027744)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Adipose tissue, hormones, and treatment of type 1 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

Subhadra C. Gunawardana

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Subhadra C Gunawardana

series ordinal

1

1 reference

27 August 2017

publication date

1 October 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

542-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814676%20AND%20SRC:MED&resulttype=core&format=json

The adipocyte as an endocrine organ in the regulation of metabolic homeostasis

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adipose tissue: the new endocrine organ? A review article

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Structural and biochemical characteristics of various white adipose tissue depots

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Brown adipose tissue: function and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Identification and importance of brown adipose tissue in adult humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Selective contribution of regional adiposity, skeletal muscle, and adipokines to glucose disposal in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Pancreas vs. islet transplantation: a call on the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Pancreas transplantation in the United States: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Recurrence of autoimmunity following pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Islet transplantation: factors in short-term islet survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

The role of incretins in glucose homeostasis and diabetes treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Relation of adiponectin to glucose tolerance status, adiposity, and cardiovascular risk factor load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin and energy homeostasis: consensus and controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin and carotid intima-media thickness in the northern Manhattan study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Role of resistin in insulin sensitivity in rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Resistin: regulation of food intake, glucose homeostasis and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Macrophage-derived human resistin exacerbates adipose tissue inflammation and insulin resistance in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Retinol binding protein: marker for insulin resistance and inflammation postburn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Insulin-like growth factor I and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

FGF21 as a therapeutic reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Update on incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Cardiovascular biology of the incretin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Regulation of adipocyte formation by GLP-1/GLP-1R signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Pharmacological targeting of glucagon and glucagon-like peptide 1 receptors has different effects on energy state and glucose homeostasis in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Making insulin-deficient type 1 diabetic rodents thrive without insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Leptin therapy in insulin-deficient type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Apelin alleviates diabetes-associated endoplasmic reticulum stress in the pancreas of Akita mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Apelin stimulates glucose utilization in normal and obese insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Apelin, a promising target for type 2 diabetes treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Incretin therapy--present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

The role of incretin therapy at different stages of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

The potential of incretin-based therapies in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Exendin-4 modulates diabetes onset in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Anti-inflammatory action of exendin-4 in human islets is enhanced by phosphodiesterase inhibitors: potential therapeutic benefits in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Decrease in {beta}-cell proliferation precedes apoptosis during diabetes development in bio-breeding/worcester rat: beneficial role of Exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Reversal of type 1 diabetes in mice by brown adipose tissue transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Inflammatory markers are increased in youth with type 1 diabetes: the SEARCH Case-Control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Brown adipose tissue, beta 3-adrenergic receptors, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Brown fat lipoatrophy and increased visceral adiposity through a concerted adipocytokines overexpression induces vascular insulin resistance and dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Brown fat as a therapy for obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Transplantation of adipose tissue and stem cells: role in metabolism and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Cyclooxygenase-2 controls energy homeostasis in mice by de novo recruitment of brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adipose tissue inflammation and insulin resistance: all obese humans are not created equal: Figure 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0300-9

Adiponectin replenishment ameliorates obesity-related hypertension

21 January 2018

1 reference

12 December 2020

Altered Plasma Adipokine Levels andin VitroAdipocyte Differentiation in Pediatric Type 1 Diabetes

1 reference

12 December 2020

Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation.

1 reference

12 December 2020

Brown fat tissue - a potential target to combat obesity

1 reference

12 December 2020

Leptin, a neuroendocrine mediator of immune responses, inflammation, and sickness behaviors

1 reference

12 December 2020

Subcutaneous transplantation of embryonic pancreas for correction of type 1 diabetes

1 reference

12 December 2020

Adiponectin decreases plasma glucose and improves insulin sensitivity in diabetic Swine

1 reference

12 December 2020

Functional human to mouse adipose tissue xenotransplantation

1 reference

12 December 2020

Restoring insulin production for type 1 diabetes.

1 reference

12 December 2020

Insulin-sensitizing properties of adiponectin

1 reference

12 December 2020

Adiponectin dysregulation and insulin resistance in type 1 diabetes

1 reference

12 December 2020

Incorporating glucagon-like peptide-1 receptor agonists into clinical practice.

1 reference

12 December 2020